Shares of the two biggest pure-play pharma companies by market value, Merck and Pfizer, have fallen 10% and 3%, respectively, this year.
Investors say pharma stocks have also lagged because many top-selling products are slated to lose patent protection in the coming years, including Abbvie’s blockbuster Humira. Another factor hurting pharma’s performance, said Jared Holz, healthcare equity strategist at Jefferies, is that the stock market currently is dominated on a given day by either a trade favoring big tech, stay-at-home stocks, or a trade favoring economically cyclical stocks.
Well yah. Biden is sold to big pharma donors. Times are good. For 1% of Americans.
Really people, with millions of lives at risk, isn't it possible to just for ONCE think beyond your 'market shares' and step away from your legalized gambling addiction? These vaccines must be free and available to everyone -- not profit vehicles for personal avaricious gain.
thank you very much for your work